Department of Neurology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
Department of Medicine, Children's Hospital of Eastern Ontario Research Institute, University of Ottawa and Division of Neurology, The Ottawa Hospital, Ottawa, Canada.
J Neuromuscul Dis. 2024;11(5):935-957. doi: 10.3233/JND-230021.
Congenital myopathies (CMs) are a diverse group of inherited muscle disorders with broad genotypic and phenotypic heterogeneity. While the literature on CM is available from European countries, comprehensive data from the Indian subcontinent is lacking.
This study aims to describe the clinical and histopathological characteristics of a cohort of genetically confirmed CMs from India and attempts to do phenotype-genotype correlation.
A retrospective chart review of genetically confirmed CMs was evaluated between January 2016 and December 2020 at the neuromuscular clinic. The clinical, genetic, and follow-up data were recorded in a pre-structured proforma as per the medical records, and the data was analyzed.
A total of 31(M: F = 14 : 17) unrelated patients were included. The median age at onset and duration of illness are 2.0(IQR:1-8) years and 6.0(IQR:3-10) years respectively. Clinical features observed were proximodistal weakness (54.8%), facial weakness (64.5%), and myopathic facies (54.8%), followed by ptosis (33.3%), and ophthalmoplegia (19.4%). Muscle histopathology was available in 38.7% of patients, and centronuclear myopathy was the most common histopathology finding. The pathogenic genetic variants were identified in RYR1 (29.0%), DNM2 (19.4%), SELENON (12.9%), KBTBD13 (9.7%), NEB (6.5%), and MYPN (6.5%) genes. Novel mutations were observed in 30.3% of the cohort. Follow-up details were available in 77.4% of children, and the median duration of follow-up and age at last follow-up was 4.5 (Range 0.5-11) years and 13 (Range 3-35) years, respectively. The majority were ambulant with minimal assistance at the last follow-up. Mortality was noted in 8.3% due to respiratory failure in Centronuclear myopathy 1 and congenital myopathy 3 with rigid spines (SELENON).
This study highlights the various phenotypes and patterns of genetic mutations in a cohort of pediatric patients with congenital myopathy from India. Centronuclear myopathy was the most common histological classification and the mutations in RYR1 followed by DNM2 gene were the common pathogenic variants identified. The majority were independent in their activities of daily living during the last follow-up, highlighting the fact that the disease has slow progression irrespective of the genotype.
先天性肌病(CMs)是一组具有广泛基因型和表型异质性的遗传性肌肉疾病。虽然欧洲国家有关于 CMs 的文献,但印度次大陆缺乏全面的数据。
本研究旨在描述印度一组经基因证实的 CMs 患者的临床和组织病理学特征,并尝试进行表型-基因型相关性分析。
对 2016 年 1 月至 2020 年 12 月在神经肌肉诊所就诊的经基因证实的 CMs 患者进行回顾性病历审查。按照病历记录,在预先制定的表格中记录临床、遗传和随访数据,并进行数据分析。
共纳入 31 名(M:F=14:17)无亲缘关系的患者。发病年龄和病程的中位数分别为 2.0(IQR:1-8)岁和 6.0(IQR:3-10)岁。观察到的临床特征包括近-远端肌无力(54.8%)、面肌无力(64.5%)和肌病面容(54.8%),其次是上睑下垂(33.3%)和眼肌麻痹(19.4%)。38.7%的患者有肌肉组织病理学检查结果,其中最常见的组织病理学发现是核内肌病。在 RYR1(29.0%)、DNM2(19.4%)、SELEON(12.9%)、KBTBD13(9.7%)、NEB(6.5%)和 MYPN(6.5%)基因中发现了致病性基因突变。在 30.3%的患者中观察到新的突变。77.4%的患儿有随访资料,中位随访时间和末次随访年龄分别为 4.5(范围 0.5-11)岁和 13(范围 3-35)岁。大多数患者在末次随访时可独立行走,仅需轻微帮助。由于核内肌病 1 型和先天性肌病 3 型伴僵硬脊柱(SELEON)导致呼吸衰竭,有 8.3%的患儿死亡。
本研究强调了印度一组儿科先天性肌病患者的各种表型和基因突变模式。核内肌病是最常见的组织学分类,RYR1 基因突变其次是 DNM2 基因,是最常见的致病性变异。在末次随访时,大多数患者日常生活活动自理,这表明无论基因型如何,疾病进展均较为缓慢。